Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer - AAPS Advances in the Pharmaceutical Sciences Series -  - Books - Springer International Publishing AG - 9783319376691 - October 6, 2016
In case cover and title do not match, the title is correct

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer - AAPS Advances in the Pharmaceutical Sciences Series Softcover reprint of the original 1st ed. 2015 edition

Price
$ 114.99
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jul 13 - 17
Add to your iMusic wish list

Not rated yet

Also available as:

Case studies are presented for the three ADCs that have received FDA approval: gemtuzumab ozogamicin (Mylotarg (R)), Brentuximab vedotin (Adcetris (R)), and ado-trastuzumab emtansine (Kadcyla (R)), as well as an ADC in late-stage clinical trials, glembatumumab vedotin (CDX-011).


262 pages, 27 black & white illustrations, 32 colour illustrations, 18 black & white tables, biograp

Media Books     Paperback Book   (Book with soft cover and glued back)
Released October 6, 2016
ISBN13 9783319376691
Publishers Springer International Publishing AG
Pages 252
Dimensions 155 × 237 × 19 mm   ·   371 g
Language German  
Editor Shen, Wei-Chiang
Editor Wang, Jeffrey
Editor Zaro, Jennica L.

Mere med samme udgiver